USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Public Funding and Large Biopharma Investments Support Technological Advancements and Improved Analysis
08-Dec-2023
North America
Market Research
K998-01-00-00-00
HC_2023_402
In recent years, single-cell analysis has changed rapidly. It began as a niche, specialized technology with few companies offering solutions, which then became commonly used in academia. Subsequently, its use has spread to areas such as biopharma, with more companies investing in the research and development (R&D) of single-cell analysis projects.
Globally, the single-cell genomics and proteomics market is growing at high rates. The United States represents about 60% of the total market and is on track to increase about 12% to 16% annually. Much of that growth is characterized by public funding, such as funding by the National Institutes of Health (NIH) and increasing biopharma investments. Greater adoption and better handling of artificial intelligence (AI) and machine learning (ML) tools will drive this market’s growth. These novel tools encourage the development of software and data analysis solutions to help researchers interpret data.
This report examines the US single-cell genomics and proteomics market and provides a forecast from 2023 to 2028. It assesses the market for single-cell analysis tools used for analytical and isolation purposes across workflows, technologies, and applications. Frost & Sullivan provides information on market concentration and evolution, leading providers, application areas, and technologies. This study will help vendors understand critical trends emerging for various application domains.
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the US Single-cell Genomics and Proteomics Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Segmentation
Key Competitors by Workflow
Growth Metrics
Growth Drivers
Growth Drivers (continued)
Growth Restraints
Forecast Assumptions
Revenue Forecast
Revenue Forecast Analysis
Revenue Forecast Analysis (continued)
Revenue Forecast by Workflow
Percent Revenue Forecast by Workflow
Forecast Analysis by Workflow
Revenue Forecast by Application
Percent Revenue Forecast by Application
Forecast Analysis by Application
Revenue Forecast by Technology
Percent Revenue Forecast by Technology
Forecast Analysis by Technology
Forecast Analysis by Technology (continued)
Pricing Trends and Forecast Analysis
Competitive Environment
Revenue Share
Revenue Share Analysis
Revenue Share Analysis (continued)
Key Companies to Watch
Key Companies to Watch (continued)
Company Solutions
Key Technologies and Workflow—Competitor Landscape
Interest in Single-cell Genomics
Single-cell Analysis Workflow Technology
Single-cell Analysis Workflow Technology (continued)
Single-cell Analysis Workflow Technology (continued)
Key Partnerships and Collaborations
Early-stage Company Funding Trends for Single-cell Analysis
Early-stage Company Funding Trends for Single-cell Analysis (continued)
Research Center Funding Trends for Single-cell Analysis
Single-cell Genomics and Proteomics Cores around the World
Growth Opportunity 1: Bioinformatics Tools and Platforms for Analyzing and Interpreting Large-scale Single-cell Data
Growth Opportunity 1: Bioinformatics Tools and Platforms for Analyzing and Interpreting Large-scale Single-cell Data (continued)
Growth Opportunity 2: Automation and High-throughput Solutions for Tissue Dissociation Processes
Growth Opportunity 2: Automation and High-throughput Solutions for Tissue Dissociation Processes (continued)
Growth Opportunity 3: The Integration of Multi-Omics Data to Drive the Development of Personalized Medicine
Growth Opportunity 3: The Integration of Multi-Omics Data to Drive the Development of Personalized Medicine (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
List of Figures
- Single-cell Genomics and Proteomics: Growth Metrics, US, 2023
- Single-cell Genomics and Proteomics: Growth Drivers, US, 2023–2028
- Single-cell Genomics and Proteomics: Growth Restraints, US, 2023–2028
- Single-cell Genomics and Proteomics: Revenue Forecast, US, 2023–2028
- Single-cell Genomics and Proteomics: Revenue Forecast by Workflow, US, 2023–2028
- Single-cell Genomics and Proteomics: Percent Revenue Forecast by Workflow, US, 2023 and 2028
- Single-cell Genomics and Proteomics: Revenue Forecast by Application, US, 2023–2028
- Single-cell Genomics and Proteomics: Percent Revenue Forecast by Application, US, 2023 and 2028
- Single-cell Genomics and Proteomics: Revenue Forecast by Technology, US, 2023–2028
- Single-cell Genomics and Proteomics: Percent Revenue Forecast by Technology, US, 2023 and 2028
- Single-cell Genomics and Proteomics: Revenue Share by Tier Classification, Global, 2023
- Single-cell Genomics and Proteomics: Competitive Mapping of Important Players’ Capabilities, US, 2023
- Single-cell Genomics and Proteomics Market: Competitor Landscape, US, 2023
- Single-cell Genomics and Proteomics Market: Publication Count, Global, 2018–2022
- Single-cell Genomics and Proteomics Market: Partnership Assessment, US, 2023
- Single-cell Genomics and Proteomics Market: Early-stage Company Funding for Single Cell Projects, US, 2019–2022
- Single-cell Genomics and Proteomics Market: Research Center Funding Trends, US, 2019–2022
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
15 Sep 2026 | Global | Market Research
Vendor Profiles: Advanced Wound Care Management Market, Global, 2025
The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...
11 Sep 2026 | Global | Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026
Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generati...
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
28 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| Author | Lucila Martin |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Proteomics Industry Trends |
| Keyword 2 | Single-Cell Genomics Market |
| Keyword 3 | Single-Cell Proteomics |
| List of Charts and Figures | Single-cell Genomics and Proteomics: Growth Metrics, US, 2023~ Single-cell Genomics and Proteomics: Growth Drivers, US, 2023–2028~ Single-cell Genomics and Proteomics: Growth Restraints, US, 2023–2028~ Single-cell Genomics and Proteomics: Revenue Forecast, US, 2023–2028~ Single-cell Genomics and Proteomics: Revenue Forecast by Workflow, US, 2023–2028~ Single-cell Genomics and Proteomics: Percent Revenue Forecast by Workflow, US, 2023 and 2028~ Single-cell Genomics and Proteomics: Revenue Forecast by Application, US, 2023–2028~ Single-cell Genomics and Proteomics: Percent Revenue Forecast by Application, US, 2023 and 2028~ Single-cell Genomics and Proteomics: Revenue Forecast by Technology, US, 2023–2028~ Single-cell Genomics and Proteomics: Percent Revenue Forecast by Technology, US, 2023 and 2028~ Single-cell Genomics and Proteomics: Revenue Share by Tier Classification, Global, 2023~ Single-cell Genomics and Proteomics: Competitive Mapping of Important Players’ Capabilities, US, 2023~ Single-cell Genomics and Proteomics Market: Competitor Landscape, US, 2023~ Single-cell Genomics and Proteomics Market: Publication Count, Global, 2018–2022~ Single-cell Genomics and Proteomics Market: Partnership Assessment, US, 2023~ Single-cell Genomics and Proteomics Market: Early-stage Company Funding for Single Cell Projects, US, 2019–2022~ Single-cell Genomics and Proteomics Market: Research Center Funding Trends, US, 2019–2022~ |
| Podcast | No |
| WIP Number | K998-01-00-00-00 |